Sign in

CIK 0001808377

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Innovative Eyewear Inc

Sign in to watch
Ticker
LUCY
Exchange
Nasdaq
Industry
Ophthalmic Goods
FY end
Dec 31
Incorporated
FL
Entity type
Operating
EIN
842794274
Phone
+1 786-910-1898
Business address
11900 BISCAYNE BLVD, STE 630, MIAMI, FL, 33181

Securities

  • LUCY Common Stock Nasdaq
  • LUCYW Warrants Nasdaq
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
  4. 4 Grant or award Chief AI & Growth Officer acquired 50,000 shares (grant or award)
  5. 4 Grant or award Chief Operating Officer acquired 90,000 shares (grant or award)
  6. 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
  7. 4 Grant or award Chief Technology Officer acquired 60,000 shares (grant or award)
  8. 8-K Event Delisting notice
  9. 8-K Event Results of operations
  10. DEF 14A Proxy Proxy Statement
  11. PRE 14A Proxy Proxy Statement (Preliminary)
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 4 Open-market sale Chief Financial Officer sold 15,533 shares at an average $0.87 ($13,491)
  15. 4 Open-market sale Chief AI & Growth Officer sold 13,627 shares at an average $0.87 ($11,874)
  16. 4 Open-market sale Chief Operating Officer sold 9,799 shares at an average $0.86 ($8,414)
  17. 4 Open-market sale Chief Executive Officer sold 27,738 shares at an average $0.88 ($24,411)
  18. 4 Open-market sale Chief Technology Officer sold 15,769 shares at an average $0.93 ($14,587)
  19. 144/A Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 1 of 14 · 266 filings